Sustainable adsorptive removal of eriochrome black T Dye using Cladophora glomerata biochar
Abstract
Water contamination by synthetic dyes poses a serious threat to aquatic ecosystems and human health, thus urgently requiring cost-effective and sustainable remediation strategies. In this research work, Cladophora glomerata algae were pyrolyzed at a slow rate (10°C/min) at 350°C for two hours in order to produce high efficiency value-added biochar and were used for the removal of an azo dye called Eriochrome Black T (EBT) from water through adsorption. The adsorbent was characterized by using various physicochemical analyses and experimental techniques. According to proximate and EDS analysis, the chosen biochar is a rich source of nutrients, including Ca, K, Mg, and P as well as carbon (47.67 wt%), oxygen (40.04 wt%), and other elements. A higher yield of 67% means that less weight is lost during pyrolysis, which allows for the production of more amount of biochar. FTIR data show that Peaks at 3853 cm-1 and 2312 cm-1 in the spectra of biochar were linked to the stretching frequency of the OH group. The abundance of OH functional groups imparts a negative charge to the biochar, providing potential active sites for dye biosorption. SEM images identified diatoms on the algal surface, diatoms are a component of ash that are present in the biochar sample. The maximum dye uptake capacity (qm) was 58.55625 mg/g at pH 2, 60 ppm dye concentration, 0.1 g biochar dosage, and 120 min of equilibrium time at room temperature. The adsorption followed the Langmuir isotherm model (R² =…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.